| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
77,400,000 |
| Market
Cap: |
687.31(M) |
| Last
Volume: |
924,004 |
Avg
Vol: |
1,535,793 |
| 52
Week Range: |
$4.32 - $9.91 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile SIGA Technologies is a commercial-stage pharmaceutical company focused on the health security markets. Co.'s primary product, TPOXX®, is a U.S. Food & Drug Administration-approved oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Constance Thomas E |
|
• • – |
2020-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
312,806 |
|
- |
|
| Plansky Michael C. |
|
• • – |
2020-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
45,000 |
|
- |
|
| Savas Paul G |
|
• • – |
2020-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
307,847 |
|
- |
|
| Kane Julie |
|
• • – |
2020-05-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
17,500 |
|
- |
|
| Savas Paul G |
|
• • – |
2019-12-09 |
4 |
B |
$4.37 |
$87,400 |
D/D |
20,000 |
292,847 |
0.01 |
- |
|
| Gomez Phillip Louis Iii |
Chief Executive Officer |
• • – |
2019-12-09 |
4 |
B |
$4.42 |
$44,200 |
D/D |
10,000 |
475,782 |
0.01 |
- |
|
| Luckshire Daniel J |
Executive VP & CFO |
• • – |
2019-12-09 |
4 |
B |
$4.39 |
$21,950 |
D/D |
5,000 |
224,943 |
0.01 |
- |
|
| Kane Julie |
|
• • – |
2019-12-09 |
4 |
B |
$4.39 |
$10,975 |
D/D |
2,500 |
2,500 |
0.01 |
- |
|
| Gomez Phillip Louis Iii |
Chief Executive Officer |
• • – |
2019-11-22 |
4 |
D |
$4.92 |
$708,618 |
D/D |
(144,028) |
465,782 |
|
- |
|
| Gomez Phillip Louis Iii |
Chief Executive Officer |
• • – |
2019-11-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
294,117 |
609,810 |
|
- |
|
| Rose Eric A Md |
|
• • – |
2019-11-22 |
4 |
D |
$4.92 |
$268,145 |
D/D |
(54,501) |
1,038,593 |
|
- |
|
| Rose Eric A Md |
|
• • – |
2019-11-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
100,000 |
1,093,094 |
|
- |
|
| Savas Paul G |
|
• • – |
2019-08-23 |
4 |
B |
$4.95 |
$49,500 |
D/D |
10,000 |
272,847 |
0.01 |
- |
|
| Savas Paul G |
|
• • – |
2019-08-09 |
4 |
B |
$5.08 |
$50,800 |
D/D |
10,000 |
262,847 |
0.01 |
- |
|
| Abrams Robin Elizabeth |
General Counsel and CAO |
• • – |
2019-07-31 |
4 |
D |
$5.60 |
$71,613 |
D/D |
(12,788) |
21,892 |
|
- |
|
| Abrams Robin Elizabeth |
General Counsel and CAO |
• • – |
2019-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
26,666 |
34,680 |
|
- |
|
| Luckshire Daniel J |
Executive VP & CFO |
• • – |
2019-07-31 |
4 |
D |
$5.60 |
$71,613 |
D/D |
(12,788) |
219,943 |
|
- |
|
| Luckshire Daniel J |
Executive VP & CFO |
• • – |
2019-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
26,666 |
232,731 |
|
- |
|
| Hruby Dennis E |
VP & Chief Scientific Officer |
• • – |
2019-06-07 |
4 |
S |
$5.58 |
$89,280 |
D/D |
(16,000) |
147,465 |
|
- |
|
| Hruby Dennis E |
VP & Chief Scientific Officer |
• • – |
2019-06-06 |
4 |
S |
$5.57 |
$94,690 |
D/D |
(17,000) |
163,645 |
|
- |
|
| Hruby Dennis E |
VP & Chief Scientific Officer |
• • – |
2019-06-05 |
4 |
S |
$5.68 |
$96,560 |
D/D |
(17,000) |
180,465 |
|
- |
|
| Antal James |
|
• • – |
2019-06-05 |
4 |
S |
$5.70 |
$171,000 |
D/D |
(30,000) |
130,875 |
|
- |
|
| Bayer Michael J |
|
• • – |
2019-06-04 |
4 |
B |
$5.74 |
$71,750 |
D/D |
12,500 |
132,244 |
0.01 |
- |
|
| Kindler Jeffrey B |
|
• • – |
2019-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
112,339 |
|
- |
|
| Constance Thomas E |
|
• • – |
2019-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
297,806 |
|
- |
|
355 Records found
|
|
Page 3 of 15 |
|
|
0.07 (0.79%) 
